Gambro/Baxter split
This article was originally published in The Gray Sheet
Executive Summary
Joint venture will expire this year, with a shared Mountain Home, Ark. dialyzer production facility reverting solely to Baxter production. Gambro also will shut plants in Germany and Japan. All three facilities produce non-synthetic dialyzers, for which less capacity is needed given a market shift to biocompatible synthetic machines, Gambro explains. The firm notes that increased synthetic production at a German plant will offset the closures...